----item----
version: 1
id: {15EB21A3-7226-4154-BA50-EE89A33FA7F7}
database: master
path: /sitecore/content/Pharma/MedtechInsight/Home/Articles/1995/07/03/Cangene Canada gets US Nucleic Acid Sequence Based Amplification NASBA patent
parent: {F0F2E7B2-9890-4F7A-8FB0-FBE26057A289}
name: Cangene Canada gets US Nucleic Acid Sequence Based Amplification NASBA patent
master: {00000000-0000-0000-0000-000000000000}
template: {11380B5D-3531-4570-B213-EFC5312266E4}
templatekey: Article

----field----
field: {A4F985D9-98B3-4B52-AAAF-4344F6E747C6}
name: __Workflow
key: __workflow
content-length: 38

{926E6200-EB76-4AD4-8614-691D002573AC}
----version----
language: en
version: 1
revision: b9b5c69d-e9d0-49bf-a974-861db19bc743

----field----
field: {5BA0578F-65B7-4C22-8233-1603D698D8A4}
name: Summary
key: summary
content-length: 609

<p>Cangene (Canada) has received a US patent for its DNA amplification technique, NASBA (Nucleic Acid Sequence Based Amplification). NASBA is already protected in Europe and Australia, but was delayed for several years in the US because of interference litigation brought by Siska Diagnostics (see Clinica No 606/7, p 19). Human diagnostic applications are licensed to Akzo Nobel subsidiary Organon Teknika (the Netherlands) which currently sells research-only tests for HIV in the US. Kits for CML translocation, factor V point mutation, hepatitis, CMV, chlamydia and MTB are currently under development.</p>
----field----
field: {2D750EFF-9058-4ABF-A7FF-57FFE5DA1E3C}
name: Title
key: title
content-length: 82

Cangene (Canada) gets US Nucleic Acid Sequence Based Amplification (NASBA) patent:
----field----
field: {446A339B-E1D9-4DE1-8B5E-DB7942EF1723}
name: Body
key: body
content-length: 609

<p>Cangene (Canada) has received a US patent for its DNA amplification technique, NASBA (Nucleic Acid Sequence Based Amplification). NASBA is already protected in Europe and Australia, but was delayed for several years in the US because of interference litigation brought by Siska Diagnostics (see Clinica No 606/7, p 19). Human diagnostic applications are licensed to Akzo Nobel subsidiary Organon Teknika (the Netherlands) which currently sells research-only tests for HIV in the US. Kits for CML translocation, factor V point mutation, hepatitis, CMV, chlamydia and MTB are currently under development.</p>
----field----
field: {0212FC0F-953B-461C-B4D9-B7483A4D4F1B}
name: Taxonomy
key: taxonomy
content-length: 155

{DA44CA46-4196-4BEB-9C53-EC7BF60AB02C}|{2360F67B-A7D7-4E2A-9C6C-5618FAE5CB5D}|{B3CB389F-B9B7-4041-9E3D-C9810F548727}|{2EDCC1FF-26E4-4C6E-AF73-0F43F0F033B8}
----field----
field: {8F4EE718-6FA0-42A5-85C4-6C8FE8B1FCD4}
name: Navigation Title
key: navigation title
content-length: 77

Cangene Canada gets US Nucleic Acid Sequence Based Amplification NASBA patent
----field----
field: {7C4FC796-1311-4DAA-81AC-85EAA2C1C108}
name: Actual Publish Date
key: actual publish date
content-length: 15

19950703T000000
----field----
field: {BDF7C8E1-869E-49FF-B9F5-854B3081A45D}
name: Created Date
key: created date
content-length: 15

19950703T000000
----field----
field: {C926A72A-39DA-446D-B78C-2A650F820A73}
name: Modified Date
key: modified date
content-length: 15

19950703T000000
----field----
field: {1616FE67-7278-4169-948E-C29B00EC8781}
name: Article Number
key: article number
content-length: 8

MT053296
----field----
field: {2C985172-2B37-4CFE-AEDE-2A42EC833941}
name: Content Type
key: content type
content-length: 38

{832554E5-EC9E-4747-8623-6770D36CAF32}
----field----
field: {31603F25-6D9C-4954-BCDE-342E1E184A30}
name: Meta Title Override
key: meta title override
content-length: 82

Cangene (Canada) gets US Nucleic Acid Sequence Based Amplification (NASBA) patent:
----field----
field: {AE1BD751-D4E7-49CB-96C4-62E995A06B51}
name: Article Category
key: article category
content-length: 4

News
----field----
field: {0F6C8F42-01DC-4E05-B63E-AA25D8AA0E09}
name: Legacy Publication
key: legacy publication
content-length: 38

{FF38DC83-07D4-43F0-8C55-84EB64FAF35A}
----field----
field: {5795FF15-0942-41FF-8A77-3B73185F5E1B}
name: Escenic ID
key: escenic id
content-length: 6

255105
----field----
field: {25BED78C-4957-4165-998A-CA1B52F67497}
name: __Created
key: __created
content-length: 16

20160622T184443Z
----field----
field: {5DD74568-4D4B-44C1-B513-0AF5F4CDA34F}
name: __Created by
key: __created by
content-length: 18

sitecore\Anonymous
----field----
field: {8CDC337E-A112-42FB-BBB4-4143751E123F}
name: __Revision
key: __revision
content-length: 36

b9b5c69d-e9d0-49bf-a974-861db19bc743
----field----
field: {D9CF14B1-FA16-4BA6-9288-E8A174D4D522}
name: __Updated
key: __updated
content-length: 16

20160622T184443Z
----field----
field: {BADD9CF9-53E0-4D0C-BCC0-2D784C282F6A}
name: __Updated by
key: __updated by
content-length: 18

sitecore\Anonymous
----field----
field: {3E431DE1-525E-47A3-B6B0-1CCBEC3A8C98}
name: __Workflow state
key: __workflow state
content-length: 38

{962542F5-554E-4DE8-BE4C-B0796FDAC854}
